List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 10 studies with search of:   "Homoharringtonine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Conditions: Myeloid Leukemia, Chronic;   Myeloid Leukemia, Chronic, Accelerated-Phase;   Blast Phase;   Myeloid Leukemia, Chronic, Chronic-Phase
Intervention: Drug: Homoharringtonine and Gleevec
2 Recruiting Open Label Study of Subcutaneous Homoharringtonine in Patients With Advanced CML
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Homoharringtonine
3 Recruiting Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors
Condition: Hematologic Tumors
Intervention: Drug: Omacetaxine
4 Withdrawn Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Drug: homoharringtonine;   Procedure: chemotherapy
5 Recruiting Homoharringtonine in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Conditions: Myeloid Leukemia, Chronic;   Myeloid Leukemia, Chronic, Accelerated-Phase;   Blast Phase;   Myeloid Leukemia, Chronic, Chronic-Phase
Intervention: Drug: Homoharringtonine
6 Completed Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Condition: Leukemia
Intervention: Drug: omacetaxine mepesuccinate
7 Completed Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Condition: Leukemia
Interventions: Drug: omacetaxine mepesuccinate;   Drug: recombinant interferon alfa
8 Active, not recruiting Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
Condition: Leukemia
Interventions: Drug: hydroxyurea;   Drug: omacetaxine mepesuccinate
9 Completed Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: omacetaxine mepesuccinate
10 Active, not recruiting Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: omacetaxine mepesuccinate;   Drug: recombinant interferon alfa

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services